Stock Price Forecast

March 15, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Orgenesis Inc chart...

About the Company

orgenesis inc (orgs) is a medical device company located in 21 sparrow cir, white plains, new york, united states.

CEO

Vered Caplan

Exchange

NASDAQ

Website

https://www.orgenesis.com/

$22M

Total Revenue

72

Employees

$24M

Market Capitalization

0.86

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ORGS News

Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference

22h ago, source:

(Nasdaq:ORGS) (“Orgenesis” or the “Company”), a global leader in decentralizing cell and gene therapies (CGTs), today announced that its CEO, Vered Caplan, will be presenting at the upcoming ...

Orgenesis Inc. Announces $2.3 Million Private Placement

15d ago, source: Business Insider

GERMANTOWN, Md., March 04, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global leader in decentralized cell and gene therapies (CGTs), announced today that ...

Orgenesis Inc. (ORGS) Stock Historical Prices & Data - Yahoo Finance

2d ago, source: Yahoo Finance

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

Orgenesis Inc ORGS

6d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

ORGS Company Profile & Executives - Orgenesis Inc. - Wall Street Journal

4d ago, source: Wall Street Journal

1 Day ORGS 1.70% DJIA -0.49% Russell 2K 0.40% Health Care/Life Sciences -0.57% ...

Orgenesis files patent for modified chimeric antigen receptor (car) molecule with enhanced anti-tumor activity

6d ago, source: Pharmaceutical Technology

Discover how Orgenesis Inc.'s patented chimeric antigen receptor (CAR) molecule with a modified hinge domain boosts anti-tumor effects and reduces inflammation. Learn about the specific amino acid ...

Orgenesis Inc. Announces $2.3 Million Private Placement

14d ago, source: Nasdaq

GERMANTOWN, Md., March 04, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global leader in decentralized cell and ...

Orgenesis Inc. (ORGS)

24d ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Orgenesis Inc. Announces $2.3 Million Private Placement

14d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...